Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: Pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis renalcarematters.com, reviewed
Kidney dosing: Aceclofenac (single-agent)Show full dosing details
- CrCl ≥60 mL/min
- Usual: 100 mg twice daily; maximum 200 mg/day (SmPC). Mild impairment: no dose change but caution.
- CrCl 30–59 mL/min
- Mild to moderate impairment: lowest effective dose with surveillance and regular kidney function checks (SmPC). Avoid with volume depletion or diuretics where possible. Short courses only; hold during intercurrent illness or volume depletion (sick-day rule; KDIGO 2024).
- CrCl 15–29 mL/min
- Severe kidney impairment: contraindicated (SmPC; no numeric threshold). Our mapping of 'severe' to CrCl <30 is a judgment.
- CrCl <15 mL/min (not on dialysis)
- Severe kidney impairment: contraindicated (SmPC; no numeric threshold). Our mapping of 'severe' to CrCl <30 is a judgment.
- Hemodialysis (intermittent)
- Contraindicated (severe kidney impairment; SmPC).
- Peritoneal dialysis
- Contraindicated (severe kidney impairment; SmPC). NSAIDs hasten loss of residual kidney function.
- CRRT
- Contraindicated; NSAIDs worsen acute kidney injury.
- Dialyzable? Not stated (over 99.7% protein-bound).
- Monitoring Kidney function regularly in mild to moderate impairment, heart failure, liver disease, diuretic use, after major surgery and in older adults; blood pressure; potassium with potassium-sparing diuretics; gastrointestinal bleeding (SmPC 4.4). Check creatinine and potassium within 1–2 weeks of starting in CKD or with an ACE inhibitor, ARB, mineralocorticoid receptor antagonist (MRA) or diuretic; avoid the NSAID + ACE inhibitor/ARB + diuretic ("triple whammy") combination and long-term use in CKD.
From the Aceclofenac monograph (renalcarematters.com, reviewed).
Use: Uses temporarily relieves minor aches and pains due to: the common cold headache backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Film-coated tablet: 100 mg/500 mg
Registered products in the Philippines
3 products registered with the Food and Drug Administration (FDA) Philippines list Aceclofenac + Paracetamol as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products3
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
ACF-PlusAceclofenac + Paracetamol | 100 mg/500 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10’s (Box of 100’s) | Rx | Mediwin PharmaceuticalsIndia | Phil Asia Pharma Inc.Importer: Ambica International Corporation | DRP-13055 | Jun 5, 2030 | |
Dolowin PlusAceclofenac + Paracetamol | 100 mg /500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Micro Labs LimitedIndia | Brown & Burk Philippines Inc. | DRP-15174 | Nov 21, 2029 | |
Zerodol-PAceclofenac + Paracetamol | 100mg/500mg Film-Coated TabletAlu/Amber-Colored PVC Blister Pack x 10's (Box of 30's) | Rx | Ipca Laboratories LimitedIndia | Blue Global (FZE) | DRP-12485 | Feb 5, 2031 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .